Answers are grounded in this paper and cite their sources.
Six patients with either acceleration or blast crisis of transformed chronic myeloid leukemia (CML) were treated with high-dose interferon alpha in combination with hydroxyurea. All patients responded to the treatment by reversal to stable chronic phase. Two of these patients responded repeatedly during their course of disease. Median time for return to chronic phase was 4 weeks. Adverse side-effects such as nausea, vomiting, hairloss, fever, prolonged cytopenia were not observed.
No takes yet. Share an insight, caveat, or question.
Jehn et al. (1995) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: